FDA Should Reinspect Chinese Plant That Makes Mifepristone, Editorial Says
FDA should reinspect a plant operated by Shanghai Hualian — a division of
More: continued here
Filed under: Abortion on February 7th, 2008
« State Health Department Ad Campaign Urges Doctors: ‘Don’t Be Silent About Smoking’ Cannabis Indicated As Possible Risk For Gum Disease In Young People »